CD40LG and myeloid sarcoma: The first aim of the present systematic review is to calculate the overall prevalence of ITMS assessed as LS-OCMBs, OCMBs, and intrathecal synthesized IgM > 0% assessed with Reiber formula [22] in different MS phenotypes.